We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$42.1B
AUM Growth
-$7.13B
Cap. Flow
+$617M
Cap. Flow %
1.47%
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$209M
2
T icon
AT&T
T
+$156M
3
XOM icon
ExxonMobil
XOM
+$122M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
WMT icon
Walmart Inc
WMT
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 18.92%
3 Financials 13.22%
4 Consumer Discretionary 8.69%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
1726
Arcus Biosciences
RCUS
$3.5B
$250K ﹤0.01%
9,880
TME icon
1727
Tencent Music
TME
$15.3B
$250K ﹤0.01%
49,750
TVRD
1728
Tvardi Therapeutics
TVRD
$23.8M
$250K ﹤0.01%
761
SBGI icon
1729
Sinclair Inc
SBGI
$974M
$249K ﹤0.01%
12,210
VRDN icon
1730
Viridian Therapeutics
VRDN
$2.18B
$248K ﹤0.01%
21,405
NBHC icon
1731
National Bank Holdings
NBHC
$1.89B
$246K ﹤0.01%
6,440
VIRX
1732
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$246K ﹤0.01%
63,406
+2,891
+5% +$8.23K
JRVR icon
1733
James River Group Holdings
JRVR
$217M
$245K ﹤0.01%
9,900
PFBC icon
1734
Preferred Bank
PFBC
$1.23B
$245K ﹤0.01%
3,600
PBI icon
1735
Pitney Bowes
PBI
$2.46B
$244K ﹤0.01%
67,470
CALX icon
1736
Calix
CALX
$2.32B
$242K ﹤0.01%
7,090
SPB icon
1737
Spectrum Brands
SPB
$2.04B
$242K ﹤0.01%
2,950
HAPN
1738
Happen Inc
HAPN
$2.16B
$241K ﹤0.01%
20,620
OWL icon
1739
Blue Owl Capital
OWL
$6.54B
$241K ﹤0.01%
24,030
NOVT icon
1740
Novanta
NOVT
$5.01B
$239K ﹤0.01%
1,970
GPMT
1741
Granite Point Mortgage Trust
GPMT
$62.8M
$236K ﹤0.01%
24,700
HLF icon
1742
Herbalife
HLF
$1.26B
$236K ﹤0.01%
11,530
RVMD icon
1743
Revolution Medicines
RVMD
$40B
$234K ﹤0.01%
11,990
HLIT icon
1744
Harmonic Inc
HLIT
$1.23B
$233K ﹤0.01%
26,900
CDNA icon
1745
CareDx
CDNA
$1.88B
$232K ﹤0.01%
10,810
FUTU icon
1746
Futu Holdings
FUTU
$14.6B
$232K ﹤0.01%
4,450
+2,250
+102% +$84.9K
ANIP icon
1747
ANI Pharmaceuticals
ANIP
$1.78B
$231K ﹤0.01%
7,793
NOG icon
1748
Northern Oil and Gas
NOG
$2.21B
$231K ﹤0.01%
9,140
EDIT icon
1749
Editas Medicine
EDIT
$411M
$229K ﹤0.01%
19,360
TELL
1750
DELISTED
Tellurian Inc.
TELL
$228K ﹤0.01%
+76,350
New +$353K

Similar funds

Ensign Peak Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
  • Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
  • Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
  • Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
  • Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
  • Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.